Friday, September 22, 2017
News Recap:
Access to Treatment:
This was a good week in terms of treatment access (but not, unfortunately, in terms of weather or seismic activity: How very, very sad). Imagine being sick or on treatment in one of these stricken areas!
In Canada Epclusa was approved for use in persons co-infected with HIV. This is very good news. Gilead Receives Approval in Canada for Expanded Indication of EPCLUSA® (Sofosbuvir/Velpat...
Click on the FB image below (top right) to view all the photos
...
HepCBC was thrilled to get an invitation to a Selkirk College student nurse-initiated seminar in Castlegar, BC March 20, 2017.
Robin Tomlin, HepCBC Board Member from nearby Robson, coordinated with the students, Janelle Jaworenko and Katrina Verigin, and their instructor Tammy McLean. Robin joined our President, Rosemary Plummer, RN, and Volunteer Cheryl Reitz for the day. Starting at 8 am sharp, we presented "Hepatitis C 101," bringing in all the latest
HepCBC considers outreach to BC's rural, remote, and First Nations communities one of our most important roles as advocates for hepatitis C treatment equity. This year started with a trip to a Prince George health fair and a webinar with the BC Centre for Disease Control comparing HCV treatment and care in BC'S urban vs rural populations. The outreach is continuing this week (March 14-19) into the Interior with Cheryl Reitz' Greyhound bus trip to Lytto...
